Completed PHASE4 INTERVENTIONAL 4-arm NCT02405104

Chlorzoxazone in Hip and Knee Arthroplasty (chlorzoxazon)

Analgetic Effects of Chlorzoxazone in Total Hip and Knee Arthroplasty

Sponsor: Northern Orthopaedic Division, Denmark

Conditions Osteoarthritis of Hip Osteoarthritis, Knee

Interventions Placebo THA TKA chlorzoxazone

Updated 9 times since 2017 Last updated: Sep 6, 2019 Started: Sep 1, 2015 Primary completion: Dec 31, 2017 Completion: Jul 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Osteoarthritis of Hip and Osteoarthritis, Knee, this trial is completed. The trial is conducted by Northern Orthopaedic Division, Denmark and has accumulated 9 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Oct 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Sep 2018 — Oct 2019 [monthly]

Active Not Recruiting PHASE4

▶ Show 4 earlier versions

Jun 2018 — Sep 2018 [monthly]

Active Not Recruiting PHASE4
May 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting
Feb 2017 — May 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northern Orthopaedic Division, Denmark

Data source: Northern Orthopaedic Division, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Farsø, Denmark